[Ventilatory and other effects of Sch 1000 aerosol in 54 patients with reversible bronchospasm].
D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use; D000336:Aerosols; D000403:Airway Resistance; D000420:Albuterol / Q000627:therapeutic use; D001285:Atropine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001986:Bronchial Spasm / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011009:Pneumoconiosis / Q000150:complications; D011407:Propane / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013147:Spirometry; D013726:Terbutaline / Q000627:therapeutic use; D013997:Time Factors
D000318:Adrenergic beta-Agonists; D000336:Aerosols; D001993:Bronchodilator Agents; D001285:Atropine; D013726:Terbutaline; D000420:Albuterol; D011407:Propane
Résultats d'une recherche sur les effets ventilatoires et associés du Sch 1000 en aérosol chez 54 patients atteints de bronchoobstruction réversible.